subject: Enzo Biochem, Inc. (enz) Swot Profile---aarkstore Enterprise Market Research Aggregation [print this page] Summary Summary
Enzo Biochem, Inc. (ENZ) SWOT Profile is a comprehensive business, functional and strategic analysis of Enzo Biochem, Inc.. The profile delves into the operations of the company to present an in-depth analysis of the various aspects related to its business. It analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, executive biographies and key competitors. The hallmark of the profile is the detailed strategic analysis of the company. This highlights and presents an unbiased view of its key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by understanding your partners, customers and competitors better.
Enzo Biochem, Inc. (Enzo Biochem) is a life sciences and biotechnology company and is principally engaged in research, development, manufacturing and marketing of diagnostic and therapeutic products based on genetic engineering, molecular biology and biotechnology. It develops research tools and also offers diagnostic services. Enzo Biochem's products are used for the treatment of cancer, infectious diseases, genetic defects. Enzo Biochem is headquartered in New York, the US.
Key Recent Developments
Mar 12, 2010: Enzo Biochem Reports Total Revenues Of $23.2 Million In Q2 Fiscal 2010
Mar 04, 2010: Enzo Biochem Appoints Robert Boorstein As Medical Director Of Enzo Clinical Labs
Mar 01, 2010: Enzo Receives Favorable Judgment In Patent Dispute Against Bayer HealthCare
Scope
- Examines key information about company for business intelligence.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented objectively. Business, strategic and operational aspects are taken into account.
- Opportunities available to the company are sized up and its growth potential assessed. Competitive and/or technological threats are highlighted.
- The profile contains valuable and critical company information business structure and operations, the company history, major products and services, prospects, key competitors, key employees, executive biographies, important locations and subsidiaries.
- The profile provides detailed financial ratios for the past five years as well as interim ratios for the last five interim periods for major public companies.
- Financial ratios presented for major public companies include revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
